Control Bionics Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CBL.AX research report →
Price Chart
About the company
Operating in Australia and North America, Control Bionics Limited and its subsidiaries specialize in the innovation, development, and market introduction of sophisticated assistive communication technologies. The company's offerings include the NeuroNode Trilogy and NeuroNode3 systems, which empower individuals facing speech and mobility challenges to control computers for speech generation, electronic correspondence, leisure activities, and remote operation of other devices. Control Bionics also provides Cosmos Connect, a versatile interface capable of managing diverse equipment like wheelchairs, robotic dining aids, and gaming consoles.
- CEO
- Jeremy E. Steele
- IPO
- 2020
- Employees
- 25
- HQ
- Cremorne, VIC, AU
Get TickerSpark's AI analysis on CBL.AX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $19.16M
- P/E
- -2.91
- PEG
- -0.07
- P/S
- 3.16
- P/B
- 2.57
- EV/EBITDA
- -2.97
- Div Yield
- 0.00%
- Gross Margin
- 5.38%
- Op Margin
- -102.97%
- Net Margin
- -107.04%
- ROE
- -98.14%
- ROIC
- -73.23%
Latest fiscal year · YoY change
- Revenue
- $6.14M+14.8%
- Gross Profit
- $4.11M+5.6%
- Op Income
- $-5,829,609
- Net Income
- $-6,108,667-3.3%
- EPS
- $-0.02+37.7%
- OCF Growth
- +13.1%
- FCF Growth
- +15.1%
- 52W High
- $0.10
- 52W Low
- $0.03
- 50D MA
- $0.07
- 200D MA
- $0.07
- Beta
- 0.10
- RSI (14)
- 42
- Avg Volume
- 722.85K
No earnings-call transcripts are available for CBL.AX yet.
- Free Float
- 35.2%
- Shares Outstanding
- 319.40M
- Float Shares
- 112.35M
Our CBL.AX coverage
Recent articles, reports, and earnings notes.
No research on CBL.AX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CBL.AX report →